Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@occams_tooth](/creator/twitter/occams_tooth)
### Social Influence [#](/creator/twitter::1858315561790545920/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [technology brands](/list/technology-brands)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[$beam](/topic/$beam) 5.77%, [$regn](/topic/$regn) #11, [$ntla](/topic/$ntla) #10, [$alny](/topic/$alny) #8, [vivo](/topic/vivo) 3.85%, [$crsp](/topic/$crsp) 3.85%, [$prme](/topic/$prme) 3.85%, [$ions](/topic/$ions) 3.85%, [$bmy](/topic/$bmy) 1.92%, [$15b](/topic/$15b) XXXX%

**Top accounts mentioned or mentioned by**
[@geneinvesting](/creator/undefined) [@rnaianalyst](/creator/undefined) [@bk7959925597715](/creator/undefined) [@astrox1111](/creator/undefined) [@biomaven](/creator/undefined) [@mckinsey](/creator/undefined) [@ttramyloid](/creator/undefined) [@bradloncar](/creator/undefined) [@dantmt](/creator/undefined) [@harrysmiuff](/creator/undefined) [@rachelaviv](/creator/undefined) [@amaymd](/creator/undefined) [@aaohns](/creator/undefined) [@erictopol](/creator/undefined) [@nytimes](/creator/undefined) [@pambelluck](/creator/undefined) [@paulmarganski](/creator/undefined) [@barry3252181](/creator/undefined) [@paulbiogeek](/creator/undefined) [@therealj_money](/creator/undefined)

**Top assets mentioned**
[BEAM (BEAM)](/topic/$beam) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Pfizer, Inc. (PFE)](/topic/$pfe) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Biogen Inc (BIIB)](/topic/$biib) [Eli Lilly and Company (LLY)](/topic/$lly) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [SuperRare (RARE)](/topic/$rare)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@occams_tooth

Social Influence #


Social category influence stocks XXXXX% cryptocurrencies XXXX% technology brands XXXX% finance XXXX%

Social topic influence $beam 5.77%, $regn #11, $ntla #10, $alny #8, vivo 3.85%, $crsp 3.85%, $prme 3.85%, $ions 3.85%, $bmy 1.92%, $15b XXXX%

Top accounts mentioned or mentioned by @geneinvesting @rnaianalyst @bk7959925597715 @astrox1111 @biomaven @mckinsey @ttramyloid @bradloncar @dantmt @harrysmiuff @rachelaviv @amaymd @aaohns @erictopol @nytimes @pambelluck @paulmarganski @barry3252181 @paulbiogeek @therealj_money

Top assets mentioned BEAM (BEAM) Regeneron Pharmaceuticals Inc (REGN) Intellia Therapeutics, Inc (NTLA) Alnylam Pharmaceuticals, Inc. (ALNY) CRISPR Therapeutics AG (CRSP) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Bristol-Myers Squibb Co (BMY) Pfizer, Inc. (PFE) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Metsera, Inc. Common Stock (MTSR) Avidity Biosciences, Inc. Common Stock (RNA) Apogee Therapeutics, Inc. Common Stock (APGE) BridgeBio Pharma, Inc. Common Stock (BBIO) Agios Pharmaceuticals, Inc. (AGIO) Biogen Inc (BIIB) Eli Lilly and Company (LLY) Arrowhead Research Corporation (ARWR) Merck & Co., Inc. (MRK) Denali Therapeutics Inc. Common Stock (DNLI) SuperRare (RARE)

creator/twitter::1858315561790545920/influence
/creator/twitter::1858315561790545920/influence